Carlo Setacci Chief Department of Surgery Vascular and Endovascular Unit University of Siena

Size: px
Start display at page:

Download "Carlo Setacci Chief Department of Surgery Vascular and Endovascular Unit University of Siena"

Transcription

1 Which carotid procedures are required to grade the stroke risk? Carlo Setacci Chief Department of Surgery Vascular and Endovascular Unit University of Siena

2 Faculty disclosure Carlo Setacci I have no financial relationships to disclose.

3 Can we elaborate a risk-score for CAS? CAS patients are HIGH risk patients for CEA (local and sistemic conditions ) Which conditions are really predictive of stroke during CAS? 2/38

4 to avoid each of the following complications Major complications Major embolic stroke Cerebral hemorrhage (including hyper-perfusion syndrome) Acute stent thrombosis Minor complications Carotid artery spasm Sustained hypotension / bradycardia Minor embolic neurological events (TIAs) Carotid artery dissection Carotid perforation Contrast encephalopathy Vascular access site complications 3/38

5 CEA risk-score Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study P M Rothwell, C P Warlow, on behalf of the European Carotid Surgery Trialists Collaborative Group Vol 353 June 19, /38

6 Stroke. 2008;37: Risk score for adverse events within 30days CAS Age >80 years, DM with HbA1c >7%, Plaque Ulceration, Contralateral stenosis > 50% 5/38

7 Stroke. 2008;37: /38

8 J Vasc Surg 2008;47:88-95 Increased prevalences of severe aortic arch calcifications and target lesion ulceration are associated with an increased risk for magnetic resonance DWI detected embolic events during CAS. Because in our study arch calcification and target lesion ulceration were more prevalent in octogenarians, this association may explain the increased risk of CAS in the elderly. 7/38

9 J Endovasc Ther 2006, Jun; 13: Our experience confirms that CAS can be offered to older patients with results comparable to those for younger people. -Anatomic complexity of the aortic arch and supra-aortic vessels is more frequent in elderly patients and this may represent a challenge for technical success. - The various age-related anatomical features can be successfully managed if CAS is performed in high volume centers by highly skilled operators. 8/38

10 Carotid Plaque and Embolic Load Echolucent plaques generated a higher number of embolic particles following CAS Ohki et al, J Vasc Surg1998; 27(3): Low GSM value plaques generated b a higher number of embolic particles following CAS Henry et al, J Endovasc Ther2002; 9(1):1-13 Carotid plaque echolucency, as measured by GSM 25, does increase the risk of stroke in carotid stenting. ICAROS study Biasi et al, Circulation 2004; 119: /38

11 J Vasc Surg 2008;47:81-7 Octogenarians had a higher incidence of 30-day adverse events at 10.0% vs 3.8% (p.029). Two variables are independently associated with 30-day stroke rate: Lesion length >15 mm (OR 6.38) Ostial involvement (OR 3.12) 10/38

12 Learning Curve What should we do? 11/38

13 CREST trial: learning curve operators <15 CAS:stroke/death rate 7.1% operators >15 CAS:stroke/death rate 3.7% 12/38

14 EVA-3S: learning curve stroke/death rate:9.6% 12 CAS or 35 stenting procedures in the supra aortic trunks, 5 of which had to be CAS 13/38

15 SPACE: learning curve stroke/death rate:6.84% 25 successful percutaneous transluminal angioplasties or stent procedures 2008: at least 30 14/38

16 Stroke. 2006;37: /38

17 Stroke and death rate at 30 days, from 2000 to 2006 for CAS and CEA 30 day Stroke and death rate Patients (%) SETACCI C. Carotid Artery Stenting in a Single Center: Are Six Years of Experience Enough to achieve the Standard of Care? EJVES. 2007;34: Years Siena experience CAS CEA As the experience increases (learning curve), the complications decrease. 16/38

18 Invited Commentary SPACE and EVA 3S trials : the need of standards for Carotid Stenting Carlo Setacci, MD; Alberto Cremonesi, MD. EJVES 2007; 33: /38

19 Invited Commentary As difficult as it is to say, we must admit that both EVA 3S and SPACE didn t match an acceptable level of physician training and credentialing. The consequences of this technical bias on the reported CAS results are left to the scientific community s evaluation. Setacci C, Cremonesi A. SPACE and EVA 3S trials : the need of standards for Carotid Stenting. EJVES 2007; 33: /38

20

21 Carotid Artery Stenting: First Consensus Document of the ICCS-SPREAD Joint Committee Alberto Cremonesi, MD; Carlo Setacci, MD; Angelo Bignamini, MD; Leonardo Bolognese, MD; Francesco Briganti, MD; Germano Di Sciascio, MD; Domenico Inzitari, MD; Gaetano Lanza, MD; Luciano Lupattelli, MD; Salvatore Mangiafico, MD; Carlo Pratesi, MD; Bernard Reimers, MD; Stefano Ricci, MD; Gianmarco de Donato, MD; Ugo Ugolotti, MD; Augusto Zaninelli, MD Gian Franco Gensini, MD Stroke.2006; 37:

22 CAS: First Consensus Document of the ICCS-SPREAD Joint Committee CAS: Training and Expertise Recommendation 10: Grade GPP [C] Once the basic skill for catheter-based intervention has been achieved by the already-active interventionist, the minimum reccomended training to achieve competence is as follows: 1. At least 150 procedures of supra-aortic vessel engagement (during diagnostic as well as interventional procedures) within 2 years, of which at least 100 as the primary operator. 2. At least 75 carotid stenting procedures, of which at least 50 as the primary operator, within a 2-year fellowship. Recommendation 11: Grade GPP [C] The minimum requirement to maintain technical skill (competence) is the number of 50 carotid stenting procedures performed and documented by each primary operator per year. Stroke.2006; 37: /38

23 Vasc Surg 2008;47: The data in this study demonstrate that high-risk patients treated with CAS achieve comparable outcomes to low-risk patients treated with CEA. Procedural risk factors specific to CAS were: age > 80 years old, aortic arch calcification, access vessel tortuosity, and stenosis as well as ICA tortuosity 21/38

24 Can we elaborate a risk-score for CAS? CEA Yes, we can CAS 22/38

25 Clinical conditions CAS risk score Age > 80 years Diabetes Hypercolesterolemia Symptomatic pts (TIA/minor Stroke) (major Stroke +1) Each factor counts 1 23/38

26 Access Score CAS risk score Risk -score Femoral 0 Radial 1 Axillary 1 CCA 2 24/38

27 Difficult Aortic Arch Risk -score Score = 2 Bovine Score = 0 Score = 1 Accessing the CCA Impact aortic anatomy Score +1 25/38

28 Supra-aortic vessel RISK SCORE 0: no tortuosity 1: point for each tortuosity either in CCA and ICA 2: severe tortuosity tortuosity +2 < /38

29 27/38 Plaque characteristics RISK SCORE Restenosis 0 Native stenosis +1 Calcified plaque +1 Ulcerated plaque +1 Long plaque +1 Controlateral +1 stenosis >50%

30 PROCEDURE Pre-dilatation +1 non protected +2 Time of procedure >30 min +2 for each extra 15 min +1 28/38

31 Operator s experience RISK-SCORE CAS < 25 6 CAS CAS CAS >75 1 CAS > /38

32 CAS risk-score SCORE Risk-score <5 low = CAS mild = CAS 2 >10 high = CAS 3 It does not exist a procedure without risk To know when to quit!!! 30/38

33 When we are beginning 31/38

34 Types of Aortic Arches Type I Normal Type II Type III Bovine Arch CAROTID STENTING:WHEN BEGINNING: TYPE III IS NOT WORTH THE RISK BE VERY SELECTIVE WITH YOUR FIRST 100 PATIENTS 32/38

35 Which lesions can we begin with? Type I: when beginning your carotid program and the Plaque? 1.5 cm or less Proximal internal carotid Non-ulcerative 33/38

36 Avoid: excessive catheter manipulation Aortic arch has its own set of embolic potential 34/38

37 Conclusion The Carotid Artery Stenting is a process of tailoring the endovascular procedure to a specific patient and a specific kind of carotid lesion. We need to have a deep knowledge of patient clinical status, vascular anatomy,carotid plaque findings and technical features of the materials (guiding catheters and sheaths, wires, balloon, stents, etc.). Only a correct learning curve could guarantee all those points 35/38

38 We need to be TRAINED!!! 36/38

39 Consideration Remind even if you are not a surgeon CEA is still working very well!!! 37/38

40

CAROTID ARTERY STENTING TECHNICALS ASPECTS. Symposium Abbott Vascular CANNES MEET 2008 Drs V PIRET, P BERGERON

CAROTID ARTERY STENTING TECHNICALS ASPECTS. Symposium Abbott Vascular CANNES MEET 2008 Drs V PIRET, P BERGERON CAROTID ARTERY STENTING TECHNICALS ASPECTS Symposium Abbott Vascular CANNES MEET 2008 Drs V PIRET, P BERGERON POINTS TO DISCUSS TO CAS INDICATIONS CONTRA INDICATIONS ANATOMICAL CONSIDERATION TECHNICS CAS

More information

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Michael R. Jaff, D.O., F.A.C.P., F.A.C.C. Assistant Professor of Medicine Harvard Medical School Director, Vascular Medicine

More information

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI Director, Peripheral Vascular Interventional Laboratory Director, Vascular & Endovascular Medicine Fellowship Program Assistant Professor of Medicine The

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting Woong Chol Kang M.D. Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Carotid Stenosis and Stroke ~25% of stroke is due to carotid disease, the reminder

More information

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL Carotid Technologies and Protection Issam D. Moussa, MD Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL Disclosure Statement

More information

Carotid Stenting and Surgery in 2016 in Russia

Carotid Stenting and Surgery in 2016 in Russia Carotid Stenting and Surgery in 2016 in Russia Novosibirsk research institute of circulation pathology named by Meshalkin, Novosibirsk, Russia Starodubtsev V., Karpenko A., Ignatenko P. Annually in Russia

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACAS (Asymptomatic Carotid Atherosclerosis Study), 65 66 ACST (Asymptomatic Carotid Surgery Trial), 6 7, 65, 75 Age factors, in carotid

More information

Why I m afraid of occlusive devices

Why I m afraid of occlusive devices Why I m afraid of occlusive devices Cannes 28.06.2008 Carlo Cernetti Cardiology Department Mirano (Venice) MEET 2008 CANNES I HAVE NOT FINACIAL INTEREST/ARRANGEMENT OR AFFILIATION CONFLICT Obstructive

More information

Limitations of Other Embolic Protection Devices - Filters. Carotid Stenting with Flow Reversal. Limitations of Distal Occlusion

Limitations of Other Embolic Protection Devices - Filters. Carotid Stenting with Flow Reversal. Limitations of Distal Occlusion Carotid Stenting with Flow Reversal Marc Schermerhorn, MD Division of Vascular and Endovascular Surgery Beth Israel Deaconess Center Boston, MA Limitations of Other Embolic Protection Devices - Filters

More information

Carotid Artery Stenting: Second Consensus Document of the ICCS/ISO-SPREAD Joint Committee

Carotid Artery Stenting: Second Consensus Document of the ICCS/ISO-SPREAD Joint Committee Review Received: April 4, 2014 Accepted: June 25, 2014 Published online: September 16, 2014 Carotid Artery Stenting: Second Consensus Document of the ICCS/ISO-SPREAD Joint Committee Gaetano Lanza a Carlo

More information

Impact of the Aortic Arch on Stent Performance

Impact of the Aortic Arch on Stent Performance Impact of the Aortic Arch on Stent Performance GianLuca Faggioli Vascular Surgery Alma Mater Studiorum UniversitY of Bologna ACST-2 Indications for carotid stenting: a preview of the potential derived

More information

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA

Carotid Artery Stenting (CAS) Pathophysiology. Technical Considerations. Plaque characteristics: relevant concepts. CAS and CEA Carotid Artery Stenting (CAS) Carotid Artery Stenting for Stroke Risk Reduction Matthew A. Corriere MD, MS, RPVI Assistant Professor of Surgery Department of Vascular and Endovascular Surgery Rationale:

More information

CAROTID ANGIOPLASTY AND STENTING UNDER PROTECTION IS BECOMING THE GOLD STANDARD TREATMENT IN HIGH AND LOW RISK PATIENTS

CAROTID ANGIOPLASTY AND STENTING UNDER PROTECTION IS BECOMING THE GOLD STANDARD TREATMENT IN HIGH AND LOW RISK PATIENTS CAROTID ANGIOPLASTY AND STENTING UNDER PROTECTION IS BECOMING THE GOLD STANDARD TREATMENT IN HIGH AND LOW RISK PATIENTS M. HENRY* MD, I. HENRY MD A. POLYDOROU MD, A.D. POLYDOROU MD M. HUGEL RN NANCY FRANCE

More information

Francesco Speziale, Laura Capoccia

Francesco Speziale, Laura Capoccia Results of a multicenter italian registry of real world CAS with the C-Guard mesh covered stent: the IRONGUARD 2 Study Francesco Speziale, Laura Capoccia Vascular Surgery Division Head of Division Prof.

More information

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai CardioLucca2014 Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee Fabrizio Tomai European Hospital e Aurelia Hospital Roma Treatment of Carotid Artery Disease

More information

CAS as first line of treatment in the future

CAS as first line of treatment in the future Azienda Ospedaliera Universitaria Senese CHIRURGIA VASCOLARE Chief:Prof. Carlo Setacci CAS as first line of treatment in the future Prof. Carlo Setacci Chief of Vascular Surgery University of Siena - Italy

More information

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective)

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective) Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective) T-Woei Tan, MD, FACS, RPVI Assistant Professor of Surgery Vascular and Endovascular Surgery Louisiana State University Health -

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control

More information

New concepts for filter protection during CAS: double filtration. Alberto Cremonesi MD, FESC

New concepts for filter protection during CAS: double filtration. Alberto Cremonesi MD, FESC New concepts for filter protection during CAS: double filtration Alberto Cremonesi MD, FESC First Experience with the PALADIN Carotid Post-Dilation Balloon with Integrated Embolic Protection Alberto Cremonesi

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Measure #344: Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Effective Clinical

More information

Protocols. Introduction

Protocols. Introduction SPREAD-STACI study: A protocol for a randomized multicenter clinical trial comparing urgent with delayed endarterectomy in symptomatic carotid artery stenosis Gaetano Lanza 1 *, Stefano Ricci 2, Francesco

More information

SCAI Fall Fellows Course Subclavian/Innominate Case Presentation

SCAI Fall Fellows Course Subclavian/Innominate Case Presentation SCAI Fall Fellows Course 2012 Subclavian/Innominate Case Presentation Daniel J. McCormick DO, FACC, FSCAI Director, Cardiovascular Interventional Therapy Pennsylvania Hospital University of Pennsylvania

More information

Case Closed Closed cell stent technology

Case Closed Closed cell stent technology Sponsored by Boston Scientific Corporation Case Closed Closed cell stent technology for carotid artery disease. Innovations in device technologies have helped to raise the bar for clinical efficacy in

More information

Comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR study

Comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR study Comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR study (RADial access for CARotide artery stenting) Zoltán Ruzsa MD PhD et al. TCT 2013 Disclosure Statement of Financial

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting JESSICA MITCHELL, ACNP CENTRAL ILLINOIS RADIOLOGICAL ASSOCIATES External Carotid Artery (ECA) can easily be identified from Internal Carotid Artery (ICA) by noticing the branches.

More information

Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC

Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC Carotid artery percutaneous treatment: back to the future Alberto Cremonesi MD, FESC GVM Care & Research - Cardiovascular Department (Cotignola Italy) Hypothesis: Does CAS present similar outcomes than

More information

Surgical Treatment of Carotid Disease

Surgical Treatment of Carotid Disease Department of Cardiothoracic & Vascular Surgery McGovern Medical School / The University of Texas Health Science Center at Houston Surgical Treatment of Carotid Disease The Old, the New, and the Future

More information

The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease

The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease The most important recommendations from the 2017 ESVS/ESC guideline on the management of carotid artery disease GJ de Borst Department of Vascular Surgery RECOMMENDATION GRADING CRITERIA What is new

More information

Siena Carotid Artery Stenting Score A Risk Modelling Study for Individual Patients

Siena Carotid Artery Stenting Score A Risk Modelling Study for Individual Patients Siena Carotid Artery Stenting Score A Risk Modelling Study for Individual Patients Carlo Setacci, MD; Emiliano Chisci, MD; Francesco Setacci, MD; Francesca Iacoponi, PhD; Gianmarco de Donato, MD; Alessandro

More information

Carotid Artery Stent: Is it ready for prime time?

Carotid Artery Stent: Is it ready for prime time? 2010 CATH LAB SYMPOSIUM Carotid Artery Stent: Is it ready for prime time? Luis F. Tami, MD, FACC, FSCAI Interventional Cardiology and Vascular Medicine Memorial Regional Hospital August 2010 CAE and CAS

More information

Subclavian artery Stenting

Subclavian artery Stenting Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence

More information

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Carotid Artery Disease How the 2014-2015 Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Christopher J. White, MD, MSCAI, FACC, FAHA, FESC Professor and Chair of Medicine Ochsner

More information

Contemporary management of brachiocephalic occlusive disease. TM Sullivan Minneapolis, MN

Contemporary management of brachiocephalic occlusive disease. TM Sullivan Minneapolis, MN Contemporary management of brachiocephalic occlusive disease TM Sullivan Minneapolis, MN WL Gore & Associates Disclosures Meeting organizer (SOAR) CR Bard Chair, CEC Bolster trial Veryan National PI, MIMICS

More information

Roadsaver the paradigm shift in carotid artery treatment. G. Torsello Münster

Roadsaver the paradigm shift in carotid artery treatment. G. Torsello Münster Roadsaver the paradigm shift in carotid artery treatment G. Torsello Münster Disclosure Speaker name:...g. Torsello... I have the following potential conflicts of interest to report: Consulting Employment

More information

Overview of Subclavian & Innominate Artery Interventions

Overview of Subclavian & Innominate Artery Interventions TCT 2016 Washington, DC, USA Tuesday November 1st, 2016 Peripheral vascular interventions Overview of Subclavian & Innominate Artery Interventions Dr Jacques Busquet Vascular & Endovascular Surgery Paris,

More information

I have the following potential conflicts of interest to report. honorarium: 1. St Jude Medical 2. Biotronik 3. Boston Scientific

I have the following potential conflicts of interest to report. honorarium: 1. St Jude Medical 2. Biotronik 3. Boston Scientific Stenting carotideo nel paziente sintomatico alla luce dei nuovi trials Savona, 11 Aprile 2015 Gioel GabrioSecco, MD, PhD Emodinamica e CardiologiaInterventistica Ospedale SantiAntonio e Biagio e Cesare

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting Natural history of the carotid stenosis Asymptomatic 80% carotid stenosis - 6% risk of stroke / year Symptomatic carotid stenosis have 10% risk of CVA at one year and 40% at 5 years

More information

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease Disclosures Your Patient Has Carotid Bulb Stenosis and a Tandem Intracranial Stenosis: How Do SAMMPRIS and Other Evidence Inform Your Treatment? UCSF Vascular Symposium 2015 Steven W. Hetts, MD Associate

More information

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS Assistant Professor of Surgery Director of Carotid Interventions Division of Vascular & Endovascular Surgery Stony Brook University

More information

My Latest Take on RCT Data: When is CEA or CAS the Best Option? The Interventional Position

My Latest Take on RCT Data: When is CEA or CAS the Best Option? The Interventional Position LINC 2016 Leipzig, Jan 26-29, 2016 My Latest Take on RCT Data: When is CEA or CAS the Best Option? The Interventional Position Horst Sievert, Iris Grunwald CardioVasculäres Centrum Frankfurt - CVC, Frankfurt

More information

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview Tips and Tricks for Tibial Intervention Donald L. Jacobs, MD C Rollins Hanlon Endowed Professor and Chair Chair of Surgery Saint Louis University SSM-STL Saint Louis University Hospital Disclosures Abbott

More information

CLINICAL TIMELINE EVA-3S CREST ICSS SPACE SAPPHIRE

CLINICAL TIMELINE EVA-3S CREST ICSS SPACE SAPPHIRE Normal Risk Symptomatic Patients: Ongoing Debate CAS vs CEA John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center University of California, Davis CLINICAL TIMELINE Randomized

More information

The variation of carotid origin, the divergent orientation of common carotid (frequent posterior and left to right direction of right common as

The variation of carotid origin, the divergent orientation of common carotid (frequent posterior and left to right direction of right common as 1 Introduction The access to the common carotid during carotid stenting is very challenging and is responsible of a significant number of embolic complications in the ipsilateral but also in the contralateral

More information

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION ARMANDO MANSILHA MD, PhD, FEBVS UNIVERSITY HOSPITAL - PORTO Disclosure of Interest Speaker name: ARMANDO MANSILHA I have the following potential conflicts

More information

Current Non-Surgical Cardiac Interventions. By Pam Bayles, RN, BSN

Current Non-Surgical Cardiac Interventions. By Pam Bayles, RN, BSN Current Non-Surgical Cardiac Interventions By Pam Bayles, RN, BSN Balloon Angioplasty & DES A balloon-tipped catheter was first used in 1964 to treat a cause of atherosclerotic disease in a patient s leg

More information

SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have the following

More information

Technique Of Carotid Stenting Decision Making Analysis To Overcome Challenges

Technique Of Carotid Stenting Decision Making Analysis To Overcome Challenges Technique Of Carotid Stenting Decision Making Analysis To Overcome Challenges Subbarao Myla MD FACC Hoag Memorial Hospital Presbyterian Newport Beach, CA USA Presenter Disclosure Information Name: Subbarao

More information

Filters versus Occlusion Balloons during CAS Is there a clear preference?

Filters versus Occlusion Balloons during CAS Is there a clear preference? Washington TCT 2005 Filters versus Occlusion Balloons during CAS Is there a clear preference? K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany Presenter Disclosure Information

More information

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA William A. Gray MD System Chief of Cardiovascular Services, President, Wynnewood, PA USA What are the possible causes of stroke in CAS? Operator error Technique (balloon sizing, wire misadventure, EPD

More information

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2 Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in a Patient with Carotid Disease

Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in a Patient with Carotid Disease Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in a Patient with Carotid Disease Jan M. Sloves RVT, RCS, FASE Technical Director New York Cardiovascular Associates Disclosures

More information

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery 2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither

More information

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008 New Trials in Progress: ACT 1 Jon Matsumura, MD Cannes, France June 28, 2008 Faculty Disclosure I disclose the following financial relationships: Consultant, CAS training director, and/or research grants

More information

CAROTID ARTERY ANGIOPLASTY

CAROTID ARTERY ANGIOPLASTY CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline

More information

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost

More information

MEET Θ symptomatic patients. K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany

MEET Θ symptomatic patients. K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany MEET Θ 2006 Why I stent asymptomatic and symptomatic patients K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany Evidence for treating symptomatic patients symptomatic patients

More information

FLEXIBLE, BALOON EXPANDABLE

FLEXIBLE, BALOON EXPANDABLE EARLY RESULTS OF A CLINICAL TRIAL OF FLEXIBLE, BALOON EXPANDABLE COVERED STENT GRAFT IN ILIAC OCCLUSIVE DISEASE Chris LeCroy Coastal Vascular and Interventional Pensacola, Florida Clinical Trial WL GORE

More information

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Tarvinder Singh, MS, MD Neurohospitalist Swedish Neuroscience Institute 1 Objectives Definition Why the urgency? Evidence/Guidelines

More information

Tips and Tricks for CAS T-CAR

Tips and Tricks for CAS T-CAR Tips and Tricks for CAS T-CAR H.-H. Eckstein, M. Kallmayer Department for Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University of Munich,, Germany Disclosures Collaborator

More information

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? Richard W. Petrella M.D. FACP,FACC,FASCI DEPARTMENT CHAIRMAN CVM&S UPMC HAMOT MEDICAL CENTER 1 LEARNING OBJECTIVES REVIEW THE RISK FACTORS FOR

More information

Carotid Revascularization

Carotid Revascularization Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical

More information

proximal protection with the MO.ma device during carotid stenting

proximal protection with the MO.ma device during carotid stenting proximal protection with the MO.ma device during carotid stenting Robert M. Bersin, MD, MPH, FACC, FSCAI Medical Director, Endovascular Services Seattle Cardiology and Swedish Medical Center -1- proximal

More information

Assessment of the procedural etiology of stroke resulting from carotid artery stenting

Assessment of the procedural etiology of stroke resulting from carotid artery stenting Assessment of the procedural etiology of stroke resulting from carotid artery stenting 1. Study Purpose and Rationale: A. Background Stroke is the 3 rd leading cause of death in the United States and carries

More information

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI How to manage TAVI related vascular complications Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI Definition VARC-2 consensus statement Complications caused by: Wire Catheter Anything related to vascular access

More information

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic State of the Art Management of Carotid Stenosis Mark R. Harrigan, MD UAB Stroke Center Professor of Neurosurgery, Neurology, and Radiology University of Alabama, Birmingham Disclosures NIH funding for

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Quality ID #345 (NQF 1543): Rate of Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS) Who Are Stroke Free or Discharged Alive National Quality Strategy Domain: Effective Clinical Care 2018

More information

Carotid Imaging. Dr Andrew Farrall. Consultant Neuroradiologist

Carotid Imaging. Dr Andrew Farrall. Consultant Neuroradiologist 20121123 SSCA http://www.neuroimage.co.uk/network Andrew Farrall Carotid Imaging Dr Andrew Farrall Consultant Neuroradiologist SFC Brain Imaging Research Centre (www.sbirc.ed.ac.uk), SINAPSE Collaboration

More information

Trans-Carotid Artery Revascularization

Trans-Carotid Artery Revascularization Trans-Carotid Artery Revascularization How I do it John Rollo Clinical Assistant Professor University of Washington Vascular Surgery 6/15/2018 DISCLOSURE John Rollo, MD, RPVI Consultant / Advisory Board:

More information

Contemporary Management of Carotid Disease What We Know So Far

Contemporary Management of Carotid Disease What We Know So Far Contemporary Management of Carotid Disease What We Know So Far Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Disclosers NONE Epidemiology 80 % of stroke are

More information

Update on Carotid Disease

Update on Carotid Disease Update on Carotid Disease L. Nelson Hopkins, MD Elad Levy, MD Adnan Siddiqui, MD,PhD Ken Snyder, MD,PhD Gates Vascular Institute LN Hopkins, MD I disclose the following financial relationship(s): President,

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

Review of clinical carotid stent procedural & long-term outcomes in. symptomatic asymptomatic. patients

Review of clinical carotid stent procedural & long-term outcomes in. symptomatic asymptomatic. patients Review of clinical carotid stent procedural & long-term outcomes in symptomatic asymptomatic patients 1 Conflict of Interest Statement Within the past 12 months, I or my spouse have had a financial interest/arrangement

More information

A Case of Contrast-Induced Encephalopathy Using Iodixanol

A Case of Contrast-Induced Encephalopathy Using Iodixanol 540 J ENDOVASC THER CASE REPORT A Case of Contrast-Induced Encephalopathy Using Iodixanol Emiliano Chisci, MD, PhD; Francesco Setacci, MD; Gianmarco de Donato, MD; and Carlo Setacci, MD Department of Surgery,

More information

Carotid Artery Stenosis

Carotid Artery Stenosis Evidence-Based Approach to Carotid Artery Stenosis Seong-Wook Park, MD Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Carotid Artery Stenosis Carotid

More information

Will Mesh-covered Stents Help Reduce the Risk of Stroke? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

Will Mesh-covered Stents Help Reduce the Risk of Stroke? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Will Mesh-covered Stents Help Reduce the Risk of Stroke? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have the following potential conflicts of

More information

ORIGINAL PAPER. Overlap stenting for in-stent restenosis after carotid artery stenting

ORIGINAL PAPER. Overlap stenting for in-stent restenosis after carotid artery stenting Nagoya J. Med. Sci. 78. 143 ~ 149, 2016 ORIGINAL PAPER Overlap stenting for in-stent restenosis carotid artery stenting Masahiro Nishihori 1,2, Tomotaka Ohshima 1, Taiki Yamamoto 1, Shunsaku Goto 1, Toshihisa

More information

New ischemic brain lesions on DW-MRI after CAS with double layer stent

New ischemic brain lesions on DW-MRI after CAS with double layer stent New ischemic brain lesions on DW-MRI after CAS with double layer stent Maria Antonella Ruffino, MD, EBIR, Claudio Rabbia, MD Vascular Radiology Città della Salute e della Scienza San Giovanni Battista

More information

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital CAROTID STENTING A 2009 UPDATE Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital TREATMENT FOR CAROTID STENOSIS Best medical management Antiplatelet therapy Antihypertensive

More information

Advances in the treatment of posterior cerebral circulation symptomatic disease

Advances in the treatment of posterior cerebral circulation symptomatic disease Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health

More information

Carotid Intravascular Imaging Technique and Indication

Carotid Intravascular Imaging Technique and Indication Nurse and Technician Forum Carotid Intravascular Imaging Technique and Indication Gianmarco de Donato Assistant Professor Vascular and Endovascular Surgery University of Siena - Italy Disclosure Speaker

More information

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)

More information

Avoiding and Managing Complications During CAS: Lessons Learned

Avoiding and Managing Complications During CAS: Lessons Learned LINC 2019 Leipzig, Germany, Jan 22-25, 2019 Avoiding and Managing Complications During CAS: Lessons Learned Horst Sievert, Ilona Hofmann, Kolja Sievert, Laura Vaskelyte, Sameer Gafoor, Stefan Bertog, Predrag

More information

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery Treatment Considerations for Carotid Artery Stenosis Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery 4.29.2016 There is no actual or potential conflict of interest in regards to this presentation

More information

Alma Mater Studiorum Università di Bologna

Alma Mater Studiorum Università di Bologna Alma Mater Studiorum Università di Bologna S.Orsola-Malpighi, Bologna, Italia Chirurgia Vascolare The volume of cerebral ischaemic lesion predicts the outcome after symptomatic carotid revascularisation

More information

Small in-stent Low Density on CT Angiography after Carotid Artery Stenting

Small in-stent Low Density on CT Angiography after Carotid Artery Stenting www.centauro.it Interventional Neuroradiology 14 (Suppl. 2): 41-46, 2008 Small in-stent Low Density on CT Angiography after Carotid Artery Stenting MIKA OKAHARA 1, HIRO KIYOSUE 2, JUNJI KASHIWAGI 1, SHINYA

More information

Update on Carotid Stenting. John R. Laird Cardiovascular Research Institute Washington Hospital Center

Update on Carotid Stenting. John R. Laird Cardiovascular Research Institute Washington Hospital Center Update on Carotid Stenting John R. Laird Cardiovascular Research Institute Washington Hospital Center Carotid Stenting What a Crazy Idea! Pathogenesis of stroke Does it make sense to think that expansion

More information

(EU), FACC (USA), FSCAI (USA)

(EU), FACC (USA), FSCAI (USA) How to reduce vascular complications of TAVI Paul TL Chiam MBBS (S pore), MMed, MRCP (UK), FAMS FRCP (Edin), FESC (EU), FACC (USA), FSCAI (USA) Cardiologist Mount Elizabeth Hospital Singapore Definition

More information

Two major randomised trials concerning the surgical treatment of carotid artery stenosis

Two major randomised trials concerning the surgical treatment of carotid artery stenosis 944 * See end of article for authors affiliations c CAROTID Correspondence to: Dr Carlo Di Mario, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK; c.dimario@rbh.nthames.nhs.uk General cardiology

More information

PREDICTORS OF PERI-PROCEDURAL OUTCOMES OF CAS A REAL WORLD EXPERIENCE

PREDICTORS OF PERI-PROCEDURAL OUTCOMES OF CAS A REAL WORLD EXPERIENCE PREDICTORS OF PERI-PROCEDURAL OUTCOMES OF CAS A REAL WORLD EXPERIENCE B. PATRICE MWIPATAYI, MMed, FCS (SA), FRACS, GD-CLINED (Melb) Department of Vascular Surgery, RPH School of Surgery, University of

More information

The value of 3D-CT angiographic assessment prior to carotid stenting

The value of 3D-CT angiographic assessment prior to carotid stenting From the Society for Vascular Surgery The value of 3D-CT angiographic assessment prior to carotid stenting Mark C. Wyers, MD, Richard J. Powell, MD, Mark F. Fillinger, Brian W. Nolan, MD, and Jack L. Cronenwett,

More information

Disclosures. Carotid artery stenting. Surveillance after Endovascular Intervention: When to Re-Intervene and What s the Evidence

Disclosures. Carotid artery stenting. Surveillance after Endovascular Intervention: When to Re-Intervene and What s the Evidence Disclosures Surveillance after Endovascular Intervention: When to Re-Intervene and What s the Evidence None 2015 UCSF Vascular Symposium Warren Gasper, MD Assistant Professor of Surgery UCSF Division of

More information

Update : Carotid Stenting and Current Trial Data

Update : Carotid Stenting and Current Trial Data Update : Carotid Stenting and Current Trial Data J. Michael Bacharach, MD, MPH, FACC, FSCAI Section Head, Vascular Medicine and Vascular Intervention North Central Heart Institute, Sioux Falls, South Dakota

More information

Technical Tips for Safe, Effective TCAR with the ENROUTE System (Silk Road Medical): When is the Procedure Contraindicated

Technical Tips for Safe, Effective TCAR with the ENROUTE System (Silk Road Medical): When is the Procedure Contraindicated Technical Tips for Safe, Effective TCAR with the ENROUTE System (Silk Road Medical): When is the Procedure Contraindicated William A Gray MD Lankenau Heart Institute Wynnewood PA USA Addressing an Unmet

More information

Octogenarians Must Be Treated With CAS

Octogenarians Must Be Treated With CAS Some Octogenarians Must Be Treated With CAS LN Hopkins, MD E Levy MD, Adnan Siddiqui,, MD, PhD Rod Samuelson MD J Mocco MD LN Hopkins, MD Potential Conflicts Consultant & research support: Boston Scientific,

More information

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund The Great Swedish Debate Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund My Disclosures Trying to bribe the moderators What do my patients expect? Balanced information

More information

Extracranial Carotid Artery Stenting With or Without Distal Protection Device

Extracranial Carotid Artery Stenting With or Without Distal Protection Device Extracranial Carotid Artery Stenting With or Without Distal Protection Device Eak-Kyun Shin MD. Professor of Medicine Division of Cardiology, Heart Center, Gil Medical Center Gacheon Medical School Incheon,

More information